UNSPSC 51182002: Testosterone

This classification denotes an androgen with the molecular formula C19H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3XMK78S47O, chemically known as 10.alpha.-androst-4-en-3-one, 17.beta.-hydroxy- but generally known as testosterone, which bears US NIH Compound Identifier 5408. European Medicines Agency schedules Testosterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10937MIG.

UNSPSC 51182002 Testosterone is a Commodity code covering hormone replacement and therapeutic testosterone products procured by state and local health systems, correctional departments, and public health agencies. State and local governments buy testosterone formulations—including injectables, gels, patches, and topicals—for clinical use in correctional facilities, state hospitals, public health clinics, and other government-operated medical settings where treatment of hypogonadism and related endocrine conditions is indicated. Purchasing bodies include state departments of health, state prison systems, county health departments, municipal hospitals, and public health authorities. Testosterone procurement under this code typically occurs through standing contracts, state pharmaceutical schedules, cooperative purchasing agreements, or competitive sealed bids on behalf of multiple agencies within a jurisdiction.

The source provided contains no recent state and local contract opportunities tagged to UNSPSC 51182002. Without posted RFPs, RFQs, IBFs, or ITBs naming this code, current market activity, response dates, issuing bodies, or geographic concentration cannot be determined from the available record.